Our mature brains may not be so old and inflexible after all. Scientists are discovering that the human brain can improve its performance to counter the consequences of cognitive impairment and even the trauma of stroke-induced brain damage.
November 16, 2011
November 14, 2011
October 25, 2011
Former Wall Street executive Gordon Murray, a former patient UCSF, wrote a book after battling brain cancer for more than a year, knowing that he had only a few months to live when he started it.
October 24, 2011
A study by researchers at the University of Mississippi Medical Center and UCSF shows that rats given a popularly prescribed antidepressant during development exhibit brain abnormalities and behaviors characteristic of autism spectrum disorders.
September 28, 2011
Brain tumor specimens taken from neurosurgery cases at the University of California, San Francisco (UCSF) Medical Center has given scientists a new window on the transformation that occurs as healthy brain cells begin to form tumors
September 26, 2011
Gallo neuroscientist Linda Wilbrecht, PhD, receives President’s Early Career Award, in recognition of her studies on the effects of drug use and stress on the adolescent brain, aimed at developing strategies to mitigate drug dependence.
September 12, 2011
An enzyme that appears to play a role in controlling the brain's response to nicotine and alcohol in mice might be a promising target for a drug that simultaneously would treat nicotine addiction and alcohol abuse in people.
September 08, 2011
Lawrence Pitts, professor emeritus of neurosurgery at UCSF, will retire in February 2012 after nearly three years as the University of California’s provost and executive vice president-academic affairs.
August 19, 2011
With four members diagnosed with multiple sclerosis (MS), three of whom are treated at the nation's leading MS Center at UCSF, a cylcing team will participate in the annual ride through the wine country to raise money to fight MS.
August 03, 2011
A new and simple risk score may aid physicians in gauging the likelihood that a common drug will cause a hemorrhagic stroke or other major bleeding in patients with atrial fibrillation, potentially allowing wider but safer use of the effective drug.